Picture This — FDA Taking Inspection Photos

Law360, New York (August 22, 2013, 9:25 PM EDT) -- In a draft guidance document issued recently, the U.S. Food and Drug Administration identified four nonexclusive categories of prohibited behavior that the agency considers to constitute “delaying, denying, limiting or refusing a drug inspection.” In particular, the new guidance expands the FDA’s power to photograph during inspections and characterizes attempts to limit photography as a prohibited behavior.

Section 707 of the Food and Drug Administration Safety and Innovation Act (FDASIA), Pub. L. 112-144, provides the FDA discretion to deem any drug adulterated that was “manufactured, processed,...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.